The Bioavailability of Dermatological and Other Topically Administered Drugs

Abstract

The literature addressing determination of the bioavailability of dermatological and other topically administered drugs has been reviewed. The various methods employed, their advantages and drawbacks, have been identified and evaluated. The state of the art and the success of topical bioavailability assessment are discussed in the light of the information presented. It is concluded that, although current methodology ensures the responsible use of topical medicaments, the techniques are, on the whole, quantitatively inadequate. A number of recommendations are proposed as possible improvements to the approaches now undertaken, and specific measurements for drugs in different therapeutic categories are suggested. The ultimate objective of this survey is to catalyze the establishment of straightforward, objective, quantitative, and reproducible methods to evaluate topical bioavailability and to reduce significantly, thereby, the incidence of bioinequivalence and pharmacological inactivity observed following drug dosing to the skin.

This is a preview of subscription content, log in to check access.

REFERENCES

  1. 1.

    B. W. Barry. Pharm J. 215:322–325 (1975).

    Google Scholar 

  2. 2.

    B. W. Barry. Dermatologica 152:47–65 (1976).

    Google Scholar 

  3. 3.

    B. W. Barry. Dermatological Formulations: Percutaneous Absorption, Marcel Dekker, New York, 1983.

    Google Scholar 

  4. 4.

    H. Schaefer, A. Zesch, and G. Stuttgen. Skin Permeability, Springer-Verlag, Berlin, 1982.

    Google Scholar 

  5. 5.

    M. Katz. In E. J. Ariens (ed.), Drug Design IV, Marcel Dekker, New York, 1973, pp. 93–148.

    Google Scholar 

  6. 6.

    M. Katz and M. K. Polano. J. Soc. Cosmet. Chem. 23:565–590 (1972).

    Google Scholar 

  7. 7.

    B. J. Poulsen. In E. J. Ariens (ed.), Drug Design IV, Academic Press, London, 1973, pp. 150–192.

    Google Scholar 

  8. 8.

    B. W. Barry. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 489–511.

    Google Scholar 

  9. 9.

    R. C. Wester and H. I. Maibach. Drug Metab. Rev. 14:169–205 (1983).

    Google Scholar 

  10. 10.

    H. Baker. J. Soc. Cosmet. Chem. 20:239–252 (1969).

    Google Scholar 

  11. 11.

    J. W. Hadgraft. J. Mond. Pharm. 3:309–321 (1967).

    Google Scholar 

  12. 12.

    J. W. Hadgraft. Br. J. Dermatol. 87:386–389 (1972).

    Google Scholar 

  13. 13.

    S. L. Yankell. Adv. Biol. Skin 12:511–522 (1972).

    Google Scholar 

  14. 14.

    J. W. Hadgraft and I. Sarkany. Br. J. Clin. Pract. 22:455–456 (1968).

    Google Scholar 

  15. 15.

    T. Higuchi. J. Soc. Cosmet. Chem. 11:85–97 (1960).

    Google Scholar 

  16. 16.

    T. Higuchi. J. Pharm Sci. 50:874–875 (1961).

    Google Scholar 

  17. 17.

    B. Idson. Drug Metab. Rev. 14:207–222 (1983).

    Google Scholar 

  18. 18.

    B. C. Lippold. Pharm. Acta Helv. 59:166–171 (1984).

    Google Scholar 

  19. 19.

    B. J. Poulsen. Br. J. Dermatol. 82:49–52 (1970).

    Google Scholar 

  20. 20.

    B. J. Poulsen. Adv. Biol. Skin 12:495–509 (1972).

    Google Scholar 

  21. 21.

    M. J. Busse, P. Hunt, K. A. Lees, P. N. D. Maggs, and J. M. McCarthy, Br. J. Dermatol. 81:103–112 (1969).

    Google Scholar 

  22. 22.

    G. A. Christie and M. Moore-Robinson. Br. J. Dermatol. 82:93–98 (1970).

    Google Scholar 

  23. 23.

    J. Ostrenga, C. Steinmetz, B. Poulsen, and S. Yett. J. Pharm. Sci. 60:1180–1183 (1971).

    Google Scholar 

  24. 24.

    M. C. Poelman, J. L. Leveque, and F. LeGall. Br. J. Dermatol. 27:158–162 (1984).

    Google Scholar 

  25. 25.

    E. R. Cooper. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 525–529.

    Google Scholar 

  26. 26.

    C. L. Gummer. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 561–570.

    Google Scholar 

  27. 27.

    S. K. Chandrasekaran and J. E. Shaw. Curr. Probl. Dermatol. 7:142–155 (1978).

    Google Scholar 

  28. 28.

    P. Grasso and A. B. G. Landsdowne. J. Soc. Cosmet. Chem. 23:481 (1972).

    Google Scholar 

  29. 29.

    B. Idson. J. Pharm. Sci. 64:901–924 (1975).

    Google Scholar 

  30. 30.

    M. Katz and B. J. Poulsen. In B. B. Brodie and J. Gillette (eds.), Handbook of Experimental Pharmacology. New Series XXVII/2, Springer-Verlag, Berlin, 1971, pp. 103–174.

    Google Scholar 

  31. 31.

    S. Riegelman. Clin. Pharmacol. Ther. 16:873–883 (1974).

    Google Scholar 

  32. 32.

    H. Schaefer, G. Stuttgen, W. Schalla, J. Gazith, and E. Bauer. Adv. Pharm. Ther. 9:223–235 (1978).

    Google Scholar 

  33. 33.

    W. Schalla, and H. Schaefer. In R. Brandau and B. J. Lippold (eds.), Dermal & Transdermal Absorption, Wissenschaftliche Verlagsgesellschaft mbh, Stuttgart, 1981, pp. 41–72.

    Google Scholar 

  34. 34.

    R. J. Scheuplein. Curr. Probl. Dermatol. 7:172–186 (1978).

    Google Scholar 

  35. 35.

    R. B. Stoughton. In T. H. Sternberg and V. D. Newcomer (eds.), Evaluation of Therapeutic Agents and Cosmetics, McGraw-Hill, New York, 1964, pp. 25–35.

    Google Scholar 

  36. 36.

    R. B. Stoughton. Dermatologica 152:27–56 (1976).

    Google Scholar 

  37. 37.

    D. E. Wurster. Curr. Probl. Dermatol. 7:156–171 (1978).

    Google Scholar 

  38. 38.

    A. M. Kligman. Drug Dev. Ind. Pharm. 9:521–560 (1983).

    Google Scholar 

  39. 39.

    S. K. Chandrasekaran, W. Bayne, and J. E. Shaw. J. Pharm. Sci. 67:1370–1374 (1978).

    Google Scholar 

  40. 40.

    E. R. Cooper, J. Pharm. Sci. 65:1396–1397 (1976).

    Google Scholar 

  41. 41.

    R. H. Guy, J. Hadgraft, and H. I. Maibach. Toxicol. Appl. Pharmacol. 78:123–129 (1985).

    Google Scholar 

  42. 42.

    R. H. Guy, and J. Hadgraft. J. Control. Rel. 1:177–182 (1985).

    Google Scholar 

  43. 43.

    R. C. Wester, P. K. Noonan, S. Smeach, and L. Kosobud. J. Pharm. Sci. 72:745–748 (1983).

    Google Scholar 

  44. 44.

    A. H. Beckett, J. W. Gorrod, and D. C. Taylor. J. Pharm. Pharmacol. 24:65–70 (1972).

    Google Scholar 

  45. 45.

    C. Muir and R. Metcalfe. J. Pharm. Biomed. Anal. 1:363–367 (1983).

    Google Scholar 

  46. 46.

    P. H. Vlasses, L. G. T. Ribeiro, H. H. Rotmensch, J. V. Bondi, A. E. Loper, M. Hichens, M. C. Dunlay, and R. K. Ferguson. J. Cardiovasc. Pharmacol. 7:245–250 (1985).

    Google Scholar 

  47. 47.

    T. R. MacGregor, K. M. Matzek, J. J. Keirns, R. G. A. Van Wayjen, A. van den Ende, and R. G. L. van Tol. Clin. Pharmacol. Ther. 38:278–284 (1985).

    Google Scholar 

  48. 48.

    L. R. Laufer, J. L. DeFazio, J. K. H. Lu, D. R. Meldrum, P. Eggena, M. P. Sambhi, J. M. Hershman, and J. L. Judd. Am. J. Obstet. Gynecol. 146:533–540 (1983).

    Google Scholar 

  49. 49.

    P. R. Imhof, T. Vuillemin, A. Gerardin, A. Racine, P. Muller, and F. Follath. Eur. J. Clin. Pharmacol. 27:7–12 (1984).

    Google Scholar 

  50. 50.

    R. C. Wester and P. K. Noonan. J. Invest. Dermatol. 70:92–94 (1978).

    Google Scholar 

  51. 51.

    R. J. Feldmann and H. I. Maibach. J. Invest. Dermatol. 48:181–183 (1967).

    Google Scholar 

  52. 52.

    R. J. Feldmann and H. I. Maibach. J. Invest. Dermatol. 52:89–94 (1969).

    Google Scholar 

  53. 53.

    R. J. Feldmann and H. I. Maibach. J. Invest. Dermatol. 54:339–404 (1969).

    Google Scholar 

  54. 54.

    H. I. Maibach and R. J. Feldman. J. Invest Dermatol. 52:381–386 (1969).

    Google Scholar 

  55. 55.

    H. I. Maibach, R. J. Feldmann, T. H. Milby, and W. F. Serat, Arch. Environ. Health 23:208–211 (1971).

    Google Scholar 

  56. 56.

    R. J. Feldmann and H. I. Maibach. Toxicol. Appl. Pharmacol. 28:120–132 (1974).

    Google Scholar 

  57. 57.

    R. J. Feldmann and H. I. Maibach. Arch. Dermatol. 109:58–59 (1974).

    Google Scholar 

  58. 58.

    T. J. Franz. Arch. Dermatol. 121:203–206 (1985).

    Google Scholar 

  59. 59.

    H. I. Maibach, M. A. Leaffer, and W. A. Skinner. Arch. Dermatol. 111:1444–1445 (1975).

    Google Scholar 

  60. 60.

    F. N. Marzulli, D. M. Anjo, and H. I. Maibach. Food Cosmet. Toxicol. 19:743–747 (1981).

    Google Scholar 

  61. 61.

    S. Nacht, D. Yeung, J. N. Beasley, D. M. Anjo, and H. I. Maibach. J. Am Acad. Dermatol. 4:31–37 (1981).

    Google Scholar 

  62. 62.

    D. A. W. Bucks. Pharm. Res. 1:148–153 (1984).

    Google Scholar 

  63. 63.

    P. K. Noonan and R. C. Wester. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 65–85.

    Google Scholar 

  64. 64.

    R. H. Guy and H. I. Maibach. J. Pharm. Sci. 72:1375–1380 (1983).

    Google Scholar 

  65. 65.

    D. M. Anjo, R. J. Feldmann, and H. I. Maibach. In P. Mauvais-Jarvais, J. Wepierre, and C. F. H. Vickers (eds.), Percutaneous Penetration of Steroids, Academic Press, New York, 1980, pp. 31–51.

    Google Scholar 

  66. 66.

    A. Rougier, D. Dupuis, C. Lotte, R. Roguet, and H. Schaefer. J. Invest. Dermatol. 81:275–278 (1983).

    Google Scholar 

  67. 67.

    D. Dupuis, A. Rougier, R. Roguet, C. Lotte, and G. Kalopissis. J. Invest. Dermatol. 82:353–356 (1984).

    Google Scholar 

  68. 68.

    A. Rougier, D. Dupuis, C. Lotte, and R. Roguet. J. Invest. Dermatol. 84:66–68 (1985).

    Google Scholar 

  69. 69.

    R. C. Wester and H. I. Maibach. In H. I. Maibach and N. J. Lowe (eds.), Models in Dermatology, Vol 2, Karger, Basel, 1985, pp. 159–169.

    Google Scholar 

  70. 70.

    R. C. Wester and H. I. Maibach. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 251–266.

    Google Scholar 

  71. 71.

    K. E. Andersen, H. I. Maibach, and D. M. Anjo. Br. J. Dermatol 102:447–453 (1980).

    Google Scholar 

  72. 72.

    M. J. Bartek, J. A. La Budde, and H. I. Maibach. J. Invest. Dermatol. 58:114–123 (1972).

    Google Scholar 

  73. 73.

    M. J. Bartek and J. A. La Budde. In H. I. Maibach (ed.), Animal Models in Dermatology, Churchill Livingstone, New York, 1975, pp. 103–120.

    Google Scholar 

  74. 74.

    R. L. Bronaugh, R. F. Stewart, and E. R. Congdon. Toxicol. Appl. Pharmacol. 62:481–488 (1982).

    Google Scholar 

  75. 75.

    N. Hunziker, R. J. Feldmann, and H. I. Maibach. Dermatologica 156:79–88 (1978).

    Google Scholar 

  76. 76.

    F. N. Marzulli, D. W. C. Brown, and H. I. Maibach. Toxicol. Appl. Pharmacol. 3:79–83 (1969).

    Google Scholar 

  77. 77.

    A. H. McGreesh. Toxicol. Appl. Pharmacol. 2:20–26 (1965).

    Google Scholar 

  78. 78.

    R. T. Tregear. Physical Functions of Skin, Academic Press, New York, 1966.

    Google Scholar 

  79. 79.

    W. G. Reifenrath, E. M. Chellquist, E. A. Shipwash, and W. W. Jederberg. Fund. Appl. Toxicol. 4:S224–S230 (1984).

    Google Scholar 

  80. 80.

    W. G. Reifenrath, E. M. Chellquist, E. A. Shipwash, W. W. Jederberg, and G. G. Krueger. Br. J. Dermatol. 111:123–135 (1984).

    Google Scholar 

  81. 81.

    R. C. Wester and H. I. Maibach. Toxicol. Appl. Pharmacol. 32:394–398 (1975).

    Google Scholar 

  82. 82.

    R. C. Wester and H. I. Maibach. In H. I. Maibach (ed.), Animal Models in Dermatology, Churchill-Livingstone, New York, 1975, pp. 133–137.

    Google Scholar 

  83. 83.

    R. C. Wester and H. I. Maibach. J. Invest. Dermatol. 67:518–520 (1976).

    Google Scholar 

  84. 84.

    R. C. Wester and H. I. Maibach. In V. Drill and P. Lazar (eds.), Cutaneous Toxicity, Academic, New York, 1977, pp. 111–126.

    Google Scholar 

  85. 85.

    R. C. Wester and P. K. Noonan. J. Invest. Dermatol. 70:92–94 (1978).

    Google Scholar 

  86. 86.

    R. C. Wester and P. K. Noonan. Int. J. Pharm. 7:99–110 (1980).

    Google Scholar 

  87. 87.

    R. C. Wester, P. K. Noonan, M. P. Cole, and H. I. Maibach. Pediat. Res. 11:737–739 (1977).

    Google Scholar 

  88. 88.

    R. C. Wester, P. K. Noonan, and H. I. Maibach. Arch. Dermatol. 113:620–622 (1977).

    Google Scholar 

  89. 89.

    R. C. Wester, P. K. Noonan, and H. I. Maibach. J. Soc. Cosmet. Chem. 30:297–307 (1979).

    Google Scholar 

  90. 90.

    R. C. Wester, P. K. Noonan, and H. I. Maibach. Arch. Dermatol. Res. 267:229–235 (1980).

    Google Scholar 

  91. 91.

    R. C. Wester, P. K. Noonan, and H. I. Maibach. Arch. Dermatol. 116:186–188 (1980).

    Google Scholar 

  92. 92.

    R. L. Bronaugh. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 267–279.

    Google Scholar 

  93. 93.

    B. J. Poulsen and G. L. Flynn. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 431–459.

    Google Scholar 

  94. 94.

    J. Houk and R. H. Guy. Submitted for publication.

  95. 95.

    R. L. Bronaugh, E. R. Congdon, and R. J. Scheuplein. J. Invest. Dermatol. 76:94–96 (1981).

    Google Scholar 

  96. 96.

    R. L. Bronaugh and R. F. Stewart. J. Pharm. Sci. 75:487–491 (1986).

    Google Scholar 

  97. 97.

    T. J. Franz. J. Invest. Dermatol. 64:190–195 (1975).

    Google Scholar 

  98. 98.

    T. J. Franz. Curr. Probl. Dermatol. 7:58–68 (1978).

    Google Scholar 

  99. 99.

    R. J. Scheuplein, I. H. Blank, G. J. Brauner, and D. J. MacFarlane. J. Invest. Dermatol. 52:63–70 (1969).

    Google Scholar 

  100. 100.

    H. Schaefer and W. Schalla. In P. Mauvais-Jarvais, J. Wepierre, and C. F. H. Vickers (eds.), Percutaneous Penetration of Steroids, Academic Press, New York, 1980, pp. 53–67.

    Google Scholar 

  101. 101.

    A. Hoelgaard and B. Mollgaard. J. Control. Rel. 2:111–120 (1985).

    Google Scholar 

  102. 102.

    K. Knutson, R. O. Potts, D. B. Guzek, G. M. Golden, J. E. McKie, W. J. Lambert, and W. I. Higuchi. J. Control. Rel. 2:67–87 (1985).

    Google Scholar 

  103. 103.

    A. S. Michaels, S. K. Chandrasekaran, and J. E. Shaw. AIChE J. 21:985–996 (1975).

    Google Scholar 

  104. 104.

    R. J. Scheuplein. In P. Mauvais-Jarvais, C. F. H. Vickers, and J. Wepierre (eds.), Percutaneous Penetration of Steroids, Academic Press, New York, 1980, pp. 1–17.

    Google Scholar 

  105. 105.

    R. J. Scheuplein. J. Invest. Dermatol. 45:334–346 (1965).

    Google Scholar 

  106. 106.

    S. Grayson and P. M. Elias. J. Invest. Dermatol. 78:128–135 (1982).

    Google Scholar 

  107. 107.

    P. M. Elias. Int. J. Dermatol. 20:1–19 (1981).

    Google Scholar 

  108. 108.

    E. Menczel, D. A. W. Bucks, R. C. Wester, and H. I. Maibach. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 43–56.

    Google Scholar 

  109. 109.

    L. B. Fisher. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1983, pp. 213–222.

    Google Scholar 

  110. 110.

    R. C. Wester and H. I. Maibach. In W. R. Hunt, M. K. Schmidt, and D. Worth (eds.), Environmental Factors in Human Growth and Development, Cold Spring Harbor Press, Cold Spring Harbor, N.Y., 1982, pp. 3–15.

    Google Scholar 

  111. 111.

    J. J. McCormack, E. K. Boisits, and L. B. Fisher. In H. I. Maibach and E. K. Boisits (eds.), Neonatal Skin: Structure and Function, Marcel Dekker, New York, 1982, pp. 149–164.

    Google Scholar 

  112. 112.

    V. A. Harpin and N. Rutter. J. Pediat. 102:419–425 (1983).

    Google Scholar 

  113. 113.

    D. R. Wilson and H. I. Maibach. In H. I. Maibach and E. K. Boisits (eds.), Neonatal Skin: Structure and Function, Marcel Dekker, New York, 1982, pp. 101–110.

    Google Scholar 

  114. 114.

    E. Christophers and A. M. Kligman. In W. Montagna (ed.), Advances in Biology of Skin. Vol. VI. Aging, Pergamon Press, New York, 1964, pp. 163–175.

    Google Scholar 

  115. 115.

    H. Tagami. Acta Dermatol. (Kyoto) 66:19–21 (1971).

    Google Scholar 

  116. 116.

    A. M. Kligman. J. Invest. Dermatol. 73:39–46 (1979).

    Google Scholar 

  117. 117.

    R. R. Kohn. Proc. Soc. Exp. Biol. Med. 131:521–522 (1969).

    Google Scholar 

  118. 118.

    R. H. Guy, E. Tur, S. Bjerke, and H. I. Maibach. J. Am. Acad. Dermatol. 12:1001–1006 (1985).

    Google Scholar 

  119. 119.

    B. A. Gilchrest. Skin and Aging Processes, CRC Press, Boca Raton, Fla., 1984.

    Google Scholar 

  120. 120.

    D. Southwell and B. W. Barry. J. Invest. Dermatol. 80:507–514 (1983).

    Google Scholar 

  121. 121.

    S. A. Akhter and B. W. Barry. J. Pharm. Pharmacol. 37:27–37 (1985).

    Google Scholar 

  122. 122.

    B. W. Barry, D. Southwell, and R. Woodford. J. Invest. Dermatol. 82:49–52 (1984).

    Google Scholar 

  123. 123.

    S. L. Bennett, B. W. Barry, and R. Woodford. J. Pharm. Pharmacol. 37:570–576 (1985).

    Google Scholar 

  124. 124.

    R. B. Stoughton. Arch. Dermatol. 118:474–477 (1982).

    Google Scholar 

  125. 125.

    R. B. Stoughton and W. O. McClure. Drug Dev. Ind. Pharm. 9:725–744 (1983).

    Google Scholar 

  126. 126.

    D. S.-L. Chow, I. Kaka, and T. I. Wang. J. Pharm. Sci. 73:1794–1797 (1984).

    Google Scholar 

  127. 127.

    S. L. Spruance, M. McKeough, K. Sugibayashi, F. Robertson, P. Gaede, and D. S. Clark. Antimicrob. Agents Chemother. 26:819–823 (1984).

    Google Scholar 

  128. 128.

    P. K. Wotton, B. Mollgaard, J. Hadgraft, and A. Hoelgaard. Int. J. Pharm. 24:19–26 (1985).

    Google Scholar 

  129. 129.

    R. O. Potts. J. Soc. Cosmet. Chem. 37:9–33 (1986).

    Google Scholar 

  130. 130.

    R. C. Cornell and R. B. Stoughton. Arch. Dermatol. 121:63–67 (1985).

    Google Scholar 

  131. 131.

    J. M. Haigh and I. Kanfer. Int. J. Pharm. 19:245–262 (1984).

    Google Scholar 

  132. 132.

    A. W. McKenzie and R. B. Stoughton. Arch. Dermatol. 86:608–610 (1962).

    Google Scholar 

  133. 133.

    V. Place, J. G. Velazquez, and K. H. Burdick. Arch. Dermatol. 101:531–537 (1970).

    Google Scholar 

  134. 134.

    B. J. Poulsen, K. Burdick, and S. Bessler. Arch. Dermatol. 109:367–371 (1974).

    Google Scholar 

  135. 135.

    R. B. Stoughton. Arch. Dermatol. 99:753–756 (1969).

    Google Scholar 

  136. 136.

    R. B. Stoughton. Arch. Dermatol. 106:825–827 (1972).

    Google Scholar 

  137. 137.

    R. Woodford and B. W. Barry. J. Invest. Dermatol. 79:388–391 (1982).

    Google Scholar 

  138. 138.

    R. Woodford and B. W. Barry. Acta Pharm. Suecica 20:53 (1983).

    Google Scholar 

  139. 139.

    R. H. Guy, E. Tur, H. I. Maibach. Int. J. Derm. 24:88–94 (1985).

    Google Scholar 

  140. 140.

    N. M. Price, L. G. Schmitt, J. McGuire, J. E. Shaw, and G. Trobough. Clin. Pharmacol. Ther. 29:414–419 (1981).

    Google Scholar 

  141. 141.

    S. K. Chandrasekaran. Drug Dev. Ind. Pharm. 9:627–646 (1983).

    Google Scholar 

  142. 142.

    P. Muller, P. R. Imhof, F. Burkart, L.-C. Chu, and A. Gerardin. Eur. Clin. Pharmacol. 22:473–480 (1982).

    Google Scholar 

  143. 143.

    P. R. Imhof. In L. F. Prescott and W. S. Nimmo (eds.), Rate Control in Drug Therapy, Churchill Livingstone, Edinburgh, 1985, pp. 201–214.

    Google Scholar 

  144. 144.

    A. Karim. Angiology 34:11–21 (1983).

    Google Scholar 

  145. 145.

    W. R. Good. Drug. Dev. Ind. Pharm. 9:647–670 (1983).

    Google Scholar 

  146. 146.

    M. Wolff, G. Cordes, and V. Luckow. Pharm. Res. 2:23–29 (1985).

    Google Scholar 

  147. 147.

    D. Arndts and K. Arndts. Eur. J. Clin. Pharmacol. 26:79–85 (1984).

    Google Scholar 

  148. 148.

    A. A. H. Lawson. In L. F. Prescott and W. S. Nimmo (eds.), Rate Control in Drug Therapy, Churchill Livingstone, Edinburgh, 1985, pp. 215–219.

    Google Scholar 

  149. 149.

    M. Hollenberg and M. Go. Am. Heart J. 108:223–231 (1984). (1984).

    Google Scholar 

  150. 150.

    S. Scheidt. Am. J. Cardiol. 56:31–71 (1985).

    Google Scholar 

  151. 151.

    “In Vitro Percutaneous Penetration,” a workshop cosponsored by FDA and AAPS, Oct.–Nov. 1986, Washington, D.C.

  152. 152.

    W. L. Epstein, V. P. Shah, and S. Riegelman. Arch. Dermatol. 106:344–348 (1972).

    Google Scholar 

  153. 153.

    W. L. Epstein, V. Shah, and S. Riegelman. Cutis 15:271–276 (1975).

    Google Scholar 

  154. 154.

    W. L. Epstein, V. P. Shah, H. E. Jones, and S. Riegelman. Arch. Dermatol. 111:1293–1297 (1975).

    Google Scholar 

  155. 155.

    S. M. Wallace, V. P. Shah, W. L. Epstein, J. Greenberg, and S. Riegelman. Arch. Dermatol. 113:1539–1542 (1977).

    Google Scholar 

  156. 156.

    H. Schaefer, G. Stuttgen, A. Zesch, W. Schalla, and J. Gazith. Curr. Probl. Dermatol. 7:80–94 (1978).

    Google Scholar 

  157. 157.

    W. Schalla and H. Schaefer. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Marcel Dekker, New York, 1985, pp. 281–303.

    Google Scholar 

  158. 158.

    A. G. Knight. Br. J. Dermatol. 91:49–55 (1974).

    Google Scholar 

  159. 159.

    T. Fischer and H. I. Maibach. Cont. Derm. 11:285–287 (1984).

    Google Scholar 

  160. 160.

    T. Fischer and H. I. Maibach. Cont. Derm. 11:134 (1984).

    Google Scholar 

  161. 161.

    T. Fischer and H. I. Maibach. Cont. Derm. 11:224–228 (1984).

    Google Scholar 

  162. 162.

    K. S. Ryatt, J. W. Feather, A. Mehta, J. B. Dawson, J. A. Cotterill, and R. Swallow. Br. J. Dermatol. 107:71–76 (1982).

    Google Scholar 

  163. 163.

    M. J. Busse. Pharm. J. 220:25–26 (1978).

    Google Scholar 

  164. 164.

    K. H. Burdick, B. J. Poulsen, and V. A. Place. JAMA 211:462–466 (1970).

    Google Scholar 

  165. 165.

    J. R. Gibson, C. Darley, J. Kirsch, E. M. Saihan, and V. S. Neild. Br. J. Dermatol. 106:445–448 (1982).

    Google Scholar 

  166. 166.

    J. R. Gibson, J. Kirsch, C. R. Darley, and C. A. Burke. Br. J. Dermatol. 109:114–116 (1983).

    Google Scholar 

  167. 167.

    J. M. Kirsch, J. R. Gibson, and C. R. Darley. Br. J. Dermatol. 108:250–252 (1983).

    Google Scholar 

  168. 168.

    J. M. Kirsch, J. R. Gibson, C. R. Darley, and C. A. Burke. Dermatologica 167:138–141 (1983).

    Google Scholar 

  169. 169.

    O. H. Mills and A. M. Kligman. Hawaii. Med. J. 41:416–420 (1982).

    Google Scholar 

  170. 170.

    R. J. Orr, N. C. Lacina, L. S. Peters, and G. L. Flynn. Am. Pharm. NS18:23–26 (1978).

    Google Scholar 

  171. 171.

    M. C. Smith, A. H. Kibbe, and T. R. Brown. J. Am. Acad. Dermatol. 11:148–151 (1984).

    Google Scholar 

  172. 172.

    C. W. Barrett, J. W. Hadgraft, G. A. Caron, and I. Sarkany. Br. J. Dermatol. 77:576–578 (1965).

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Richard H. Guy.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Guy, R.H., Guy, A.H., Maibach, H.I. et al. The Bioavailability of Dermatological and Other Topically Administered Drugs. Pharm Res 3, 253–262 (1986). https://doi.org/10.1023/A:1016303216873

Download citation

  • topical drugs, bioavailability
  • percutaneous absorption
  • pharmacology, cutaneous
  • bioequivalence, topical